Fresh Recalls

FDAClass I · Drug · Recall D-0851-2026 · Recalled September 9, 2026

Glutathione 200 mg/mL recall — OPTIMAL BALANCE PHARMACY

Agency report date: September 9, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Glutathione 200 mg/mL
Company / brand
OPTIMAL BALANCE PHARMACY
Lot / serial / date codes
Lot#: LG342009076, Beyond Use Date: 10/4/26
Distribution
USA Nationwide.
Agency product description and boundaries

Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutathione, Ascorbic Acid, Benzyl Alcohol & sterile water for injection, For IM or IV Injection Use Only, RX only, Optimal Balance Pharmacy, 2204 Cypress Creek Pkwy Suite F, Houston, TX 77090

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class I: most serious — reasonable probability of serious health consequences or death.

Affected product: Glutathione 200 mg/mL recall status

3. Open the official notice or contact

Official recall ID
D-0851-2026
Brand
All OPTIMAL BALANCE PHARMACY recalls
Classification
Class I
Units affected
53 vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Houston, TX, United States
Firm address
2204 Cypress Creek Pkwy, N/A, 77090-3113

Identifying details (verbatim from the notice)

Product codes / lots
Lot#: LG342009076, Beyond Use Date: 10/4/26
Distribution
USA Nationwide.
Firm notified the public via
E-Mail
FDA event ID
99662
Recall initiated
August 5, 2026
FDA classified
September 16, 2026
FDA report date
September 9, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 12:00 PM UTC. Record retrieved October 22, 2026 at 12:00 PM UTC.

Report a data error on this page